Market Access Strategy
A single strategy connecting your regulatory approval to a realistic path to market.
Support from approval to market — pricing, reimbursement, HTA, and payer engagement, so your regulatory work actually translates into patients accessing your medicine.
👆 Click each stage — from regulatory to commercial
Illustrative overview of a typical approval-to-launch journey
Direct, transparent communication at every stage — no middlemen, no fine print.
Flexible plans based on your product's market and launch timeline.
No handoffs between regulatory approval and market access planning.
Direct knowledge of both regulatory requirements and payer expectations.
We review your approval status and where market access planning should begin.
We define the pricing and reimbursement approach for your target markets.
We prepare your HTA submission and support engagement with payers.
We support your launch and stay accountable for post-approval commitments.
A single strategy connecting your regulatory approval to a realistic path to market.
Pricing and reimbursement strategy tailored to your target markets and product profile.
Health Technology Assessment dossiers prepared ahead of approval, not scrambled together after.
Structured engagement with payers to support access decisions in your target markets.
A readiness plan connecting regulatory approval to a commercially viable launch.
Ongoing management of post-approval studies and commitments (such as PASS/PAES) after launch.
Without a pricing and reimbursement strategy, an approved medicine can sit unavailable to the patients who need it.
Market access planning starts before approval lands, not once it's already a scramble.
Teams that focused only on regulatory approval often discover HTA requirements too late to plan properly.
Health Technology Assessment requirements are anticipated, not discovered after the fact.
PASS/PAES commitments can slip once attention shifts to the next program.
Someone stays responsible for your post-approval obligations, even after launch is underway.
Direct knowledge of both regulatory requirements and payer expectations, not just one side of the process.
No handoffs between the regulatory team and the market access team — one continuous thread.
Flexible plans based on your target markets and launch timeline.
We'll review your approval timeline and tell you, with no obligation, what market access work should already be underway.
We typically respond within 24-48 business hours.
.
.
| Cookie | Duración | Descripción |
|---|---|---|
| cookielawinfo-checkbox-analytics | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Analytics". |
| cookielawinfo-checkbox-functional | 11 months | The cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional". |
| cookielawinfo-checkbox-necessary | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary". |
| cookielawinfo-checkbox-others | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Other. |
| cookielawinfo-checkbox-performance | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Performance". |
| viewed_cookie_policy | 11 months | The cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data. |